EP0057
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EP0057, covering 2023-08-02 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer [Phase 1, Phase 2]